Four primary data sources were used for this analysis and were selected from the most recent complete data sets available: (1) SCD rates from the Oregon SUDS population-based surveillance between
S udden cardiac death (SCD) is characterized by sudden circulatory collapse caused by cardiac arrhythmia. A majority of cases occur in the setting of chronic or acute ischemic heart disease. 1 There is little information on the public health burden from SCD around the world, and it was not reported as part of the Global Burden of Disease Study. 2 Estimates of annual incidence of SCD in the United States range between 180 000 and 450 000, 3 corresponding to between 7% and 18% of all deaths in the United States. The high degree of variability in these estimates is because of limitations in data regarding mode of cardiovascular death. Death certificate reporting provides annual national estimates for many diseases but has proven inaccurate for SCD. [4] [5] [6] Cohort studies and randomized trials have produced important insights into heart disease. However, inferences on incidence and burden are limited because few studies are designed to prospectively identify SCD and it often takes many years to accrue sufficient numbers of cases for analysis. Detailed knowledge of SCD is critical for targeting SCD-specific prevention and treatment at the population level (designing and evaluating emergency medical response systems and automatic external defibrillator deployments) and patient level (optimizing use of implantable cardioverter-defibrillators and developing new methods targeting arrhythmic death prevention).
Clinical Perspective on p 217
We sought to provide estimates of national SCD incidence and burden of premature death based on data from the Oregon Sudden Unexpected Death Study (SUDS) in Portland, OR, and compare these with other causes of death nationwide. Oregon SUDS is a multisource, population-based study of SCD among all ages in a community of 680 000 people. We estimated the burden of premature death using a well-accepted metric, years of potential life lost (YPLL). YPLL measures the total lost years of life for all individuals with a disease compared with individuals who live to a normal life expectancy. 2002 
Surveillance and Adjudication of SCD
Annual cases of SCD were determined from 3 years of prospective, multiple-source surveillance in Multnomah County, OR. Cases were identified as previously described based on prospective surveillance methods using original information from the local emergency medical response system, medical examiner, and all area hospitals. 4, 11 Available records were gathered from clinics, hospitals, medical examiner reports, and emergency medical response system reports. Three physicians reviewed all records to adjudicate cause and mode of death. A 2-step approach is used for SCD adjudication. Based on arrest records that include circumstances, review of tracings captured by emergency medical response system, and any known medical history, the patient is preliminarily categorized as SCD or non-SCD. After further record review including prearrest medical records, postresuscitation medical records, and autopsy when available, the SCD cases can be recategorized as non-SCD if noncardiac causes of arrest are identified. At either stage, the most definitive data are used to determine death in the case of any conflicting information (eg, an autopsy would supersede most information from postarrest medical diagnostics, and recordings of rhythm/vitals would supersede bystander observations of unresponsiveness).
Definitions
The following definitions were used: SCD referred to unexpected death without an obvious noncardiac cause occurring within 1 hour of symptom onset (witnessed) or within 24 hours of last being observed in normal health (unwitnessed). 12 Cases with likely noncardiac causes of death were excluded (for instance, diagnosed pulmonary embolism, known metastatic cancer, or drug overdose). Deaths were verified by searching National Death Index records, published obituaries, and State of Oregon death certificates. Sudden cardiac arrest included all cases of SCD, as well as patients surviving to hospital discharge. Burden of premature death was used as a descriptor of magnitude of YPLL (see description below). Overall cancer referred to all forms of cancer, independent of site or histology. Overall heart disease referred to any form of heart disease, including SCD. Leading causes of death referred to those tracked and reported by the CDC's National Center for Health Statistics National Vital Statistics System. Individual cancer referred to a cancer originating from a specific anatomic site. Examples include breast cancer and prostate cancer. Base-case estimates referred to national extrapolation of Multnomah County, Oregon, rates of SCD, and sudden cardiac arrest using only age and sex adjustment.
Multnomah County SCD rates
Data from 3 years of active surveillance among residents of all ages in Multnomah County were used. Each adjudicated SCD case was assigned to a sex and age category. Eighteen age categories were used: seventeen 5-year categories (0-5 years to 80-85 years) and 1 category of ≥85 years. The total number of deaths during 3 years for each age-sex category was divided by 3, yielding numerators for each age-sex category. US Census Bureau data for the Multnomah County population at the middle time point of the study period for each age-sex category constituted the denominators for the categories and allowed calculation of the population incidence of SCD for each age-sex category. These category incidences formed the basis for subsequent calculation of YPLL.
National SCD Estimates
National incidences of SCD were estimated for women, men, and overall using 2 methods. The first adjustment method extrapolated the sex-and age-stratified rates from Oregon SUDS to the nation overall, using conventional age-standardization techniques with the 2009 US population as the reference. National counts of SCD were determined by multiplying the estimated incidences by the national population. Estimates of SCA (combination of SCD and nonlethal arrests meeting criteria above) were calculated in the same manner as SCD and are reported in Table 1 for comparison.
A second national extrapolation technique, cardiac death risk adjustment, was used to adjust for potential regional differences in SCD rates beyond that explained by differences in population age and sex characteristics. For this extrapolation technique, we assumed that the ratio of SCD rates between each state and Multnomah County varied to the same degree as the ratio of overall heart disease mortality between each state and Multnomah County. The Multnomah County population-based SCD rate for each age-sex category was multiplied by the population of the corresponding age-sex category in each of the 50 states plus District of Columbia to yield an estimated state SCD event count. Each state count (stratified by sex) was multiplied by the ratio of overall heart disease mortality between that state and Multnomah County, 8,13 resulting in an adjusted SCD count. The sum of the adjusted counts yielded the adjusted national totals for SCD. The totals were divided by the national population to create an estimate of national SCD rates adjusted for differences by age, sex, and state. Implicit to this technique were 2 assumptions: (1) regional differences in SCD rates mirror the differences in overall cardiac death risk, and (2) differences in cardiac death risk between regions are constant across sex and age categories. *95% uncertainty intervals are shown in parentheses and were calculated using the gamma distribution method. Incidence rates are expressed per 100 000 national population and were extrapolated from Multnomah County data (with and without adjustment for statespecific differences in overall cardiac death risk, as described in the Methods section). Sudden cardiac death refers to patients who died within 1 hour of symptom onset if witnessed or within 24 hours of last being seen alive in normal state if unwitnessed. Sudden cardiac arrest refers to all patients with sudden cardiac death as well as those who survived until hospital discharge after resuscitation for a primary arrhythmia.
National Rates of Death From Non-SCD Causes
Death counts from common diseases were identified from national death certificate summary reports that were stratified by the same age-sex categories as the Multnomah County data. Total counts for each sex were divided by the national population of that sex during the year of measurement (2008 for cancers and 2009 for all other causes of death) and multiplied by 100 000 to yield a national population-based rate. Counts within each age-sex category were used for YPLL comparisons.
Years of Potential Life Lost
YPLL was calculated for SCD and other causes of death by multiplying the estimated number of nationwide deaths in each age-sex category by the 2009 US population life expectancy at the midpoint of that age category. For each cause of death, YPLL was totaled for all age categories. An additional analysis for YPLL from SCD was performed using the cardiac death risk adjustment described above.
Statistical Analysis
Calculations were performed using Microsoft Excel version 14.0 and SAS version 9.4. The statistical level of uncertainty surrounding national SCD incidence rates was calculated using 95% confidence intervals (CIs) according to the gamma distribution method 14 as suggested for age-adjusted rates 15 as follows:
where R is the age-adjusted rates, m is the number of age groups, d i is the number of deaths in age group i, P i is the population in age group i, and s i is the proportion of the standard population in age where v is the variance, w M is the maximum likelihood of the weights s i /p i , 1−α is the CI desired, and ( ) X x 2 1
− is the inverse of the X 2 distribution with x df. 95% Uncertainty intervals for YPLL from SCD were calculated based on the 2.5th and 97.5th percentile distributions from Monte Carlo simulations using 10 000 sample draws with binomial distributions of the Multnomah County SCD rates.
According to convention for national demography reporting (as used by the US Centers for Disease Control and Prevention and others), counts, rates, and YPLL for nationally measured diseases were reported and compared without use of inferential statistical testing because they represent directly measured national data rather than samples of a population.
Informed Consent
This study was approved by the institutional review boards of all area hospitals. All living patients provided informed consent for participation.
Results

Population Characteristics
The population of Multnomah County Oregon in 2003 was 679 348 and grew to 727 721 by 2009. County residents were 83% white and 6% black, with 17% of all races reporting Hispanic ethnicity. The population of the United States in 2003 was 290 107 933 and grew to 306 771 529 by 2009. US residents were 80% white and 13% black, with 14% reporting Hispanic ethnicity.
National SCD Estimates
The national age-and sex-adjusted rate for SCD in the base-case analysis was 60 per 100 000 population (95% CI=54-66 per 100 000). Rates among women were 45 per 100 000 (95% CI=37-53 per 100 000) and among men were 76 per 100 000 (95% CI=66-87 per 100 000). There were an estimated 183 001 SCD cases annually (95% uncertainty inter-val=164 218-203 205) for both sexes. Adding cardiac death risk adjustment (adjusting for age, sex, and state variability in heart disease mortality) resulted in an estimated national SCD rate point estimate of 69 per 100 000 and a national total of 212 910 cases ( Table 1 ).
Comparisons of National Rates of SCD With Other Leading Causes of Death
Among women, overall heart disease and cancer were the leading causes of death, with rates of 188 per 100 000 and 174 per 100 000, respectively ( Table 2 ). Rates of cerebrovascular disease (49 per 100 000), chronic lower respiratory disease (46 per 100 000), lung cancer (45 per 100 000), and SCD (45 per 100 000; 95% CI, 37-53 per 100 000) were all in a similar range. Among men, heart disease and cancer death rates were 205 per 100 000 and 197 per 100 000, respectively (Table 3) . Deaths from SCD (76 per 100 000; 95% CI, 66-87 per 100 000) exceeded all other individual causes of death, including lung cancer, accident, chronic lower respiratory disease, cerebrovascular disease, diabetes mellitus, prostate cancer, and colorectal cancer.
Comparisons of Burden of Premature Death From SCD With Other Leading Causes of Death
Total YPLL from SCD for men (2.04 million; 95% uncertainty interval, 1.86-2.23 million) was greater than from chronic lower respiratory disease (0.72 million), cerebrovascular disease (0.62 million), and diabetes mellitus (0.53 million). SCD accounted for 50% of all YPLL caused by overall heart disease (4.11 million) and trailed only overall cancer (4.32 million) and accidental death (2.38 million) among noncardiovascular causes of death. Use of the cardiac death risk adjustment method increased the YPLL from SCD to 2.36 million. Among women, total YPLL for SCD (1.29 million; 95% uncertainty interval, 1.13-1.45 million) was greater chronic lower respiratory disease (0.87 million), cerebrovascular disease (0.78 million), and Alzheimer disease (0.35 million). It was of borderline greater magnitude than accidental death (1.17 million). SCD accounted for 41% of YPLL caused by overall heart disease (3.11 million) and was exceeded in magnitude only by overall cancer (4.47 million) among noncardiovascular causes of death. Use of the cardiac death risk adjustment method increased the estimated YPLL from SCD to 1.49 million.
For men, the burden of YPLL for SCD and most major diseases began to increase between 35 and 45 years of age, whereas that of accidental death was most pronounced between 10 and 60 years of age (Figure 1 ). For women, there was a similar early peak of YPLL from accidental death, although of smaller magnitude. Heart disease and SCD premature death burdens began to increase more slowly, with lower peaks relative to overall cancer. Unlike heart disease in men and unlike cancer in both sexes, YPLL from heart disease in women continued to climb in old age.
SCD was responsible for a greater burden of premature death than all individual cancers for each sex (Figure 2 ). Among men aged <65 years, YPLL from SCD was more than double that from any individual cancer.
Discussion
This study demonstrates the large public health burden of SCD, which is responsible for 40% to 50% of YPLL from heart disease. The incidence and premature death burden from SCD exceeded that of any individual cancer in both men and women. Among women, SCD exceeded all noncardiac causes of premature death except overall cancer. Among men, SCD exceeded all except overall cancer and accidents. The estimated annual national incidence of SCD using standard age and sex adjustment was 183 000 (95% uncertainty interval=164 000-203 000). The point estimate for national SCD incidence after adding cardiac death risk adjustment increased to 213 000. This study not only adds to previous reports of SCD incidence 3 but also places the problem of SCD in broader societal perspective by comparing it with other causes of death. Because of lower population-based rates of SCD in Oregon, the actual national burden of premature death from SCD is likely even greater than we have reported in our base-case estimate. Adjusting for regional differences in SCD rates resulted in a 15% higher burden of YPLL from SCD for both men and women.
To our knowledge, this is the first study to estimate national rates of SCD using prospective surveillance systems with rigorously adjudicated cause-of-death information on patients of all ages. This allows for the comparison of premature death between SCD and other causes. The societal burden of premature death is an important factor that should help to guide relative allocation of resources for studying, preventing, and treating diseases. The high burden of SCD stands in contrast to the limited scientific knowledge regarding its incidence, origin, and risk factors. 1, 3, 16 This may be a manifestation of the modest epidemiological surveillance efforts dedicated to heart disease overall. Heart disease deaths are tracked nationally only by use of death certificates as part of the CDC's National Vital Statistics System. This is of limited use for detailed epidemiological research, and it has been repeatedly shown to inaccurately reflect the mode of cardiovascular death compared with detailed clinical review of cases. [4] [5] [6] Incidence and recurrent event data for heart disease, reported annually in the American Heart Association's Heart Disease and Stroke Statistics updates, are 17 These 3 studies represent an estimated total population of 1 million (<0.5% of the US population). Many of the national inferences of heart disease are derived from 10 333 patients in 2 cohorts of FHS. There are similarly few efforts worldwide to track SCD burden, and it is not reported as part of the Global Burden of Diseases Study. 2 The US approach to cancer epidemiology serves as a contrast and potential model for cardiovascular epidemiology. The Surveillance, Epidemiology, and End Result (SEER) registry, established in 1973 as part of the National Cancer Institute, collects detailed information about patient characteristics, tumor characteristics, clinical treatments, and patient outcomes for cancer cases in 20 geographic areas. 18 It encompasses 28% of the US population, and the registry's demographics are representative of the nation as a whole. The director of the Division of Cancer Prevention at the National Cancer Institute has stated that "SEER is a mainstay of the National Cancer Program… rational leadership of National Cancer Institute would not be possible without SEER." 19 The magnitude of SCD illustrated in the present study and its inherent limitations (see below) argue for an improved epidemiological surveillance system for cardiovascular death that is akin to SEER. With better knowledge of the nature of SCD, more effective investigation into mechanisms, prevention, and treatment can be undertaken. For a disorder such as SCD with myriad etiologic pathways, such research is particularly important.
Because no nationally representative epidemiological studies of SCD currently exist, our estimates based on the Oregon SUDS study provide the most accurate available comparison of the burden of premature death from SCD relative to other diseases. The most important limitation is the use of a single metropolitan area. In lieu of a national cardiovascular epidemiological registry system, a majority of inferences about incidence and trends of cardiovascular disease have been derived from cohorts much smaller than Multnomah County's population. 17 At this point, Multnomah County is the only source of data possessing all of the requisite attributes for this analysis. In particular, cause-of-death and mode-of-death adjudication must be robust to prevent inclusion of cardiac arrests that are not primarily arrhythmic (eg, primary respiratory failure) or occur in the setting of a known terminal illness (eg, metastatic cancer) from leading to an overestimation of SCD rates. For example, despite other strengths of the ROC Epistry-Cardiac Arrest study, it seems to have overestimated the rate of SCD in the Portland metropolitan area (60 per 100 000 in Oregon SUDS with detailed clinical mode-of-death adjudication; 71 per 100 000 in ROC Epistry-Cardiac Arrest). 20 Another important limitation is that the death certificate data used for non-SCD death are prone to disease miscategorization (although likely to a lesser degree than death certificate-based SCD data). Nonetheless, these data sources are preferred by CDC for nationwide comparisons, and alternative sources are not available. Finally, YPLL estimates in the present study are generally less than those from the US portion of the Global Burden of Diseases Study. 21 This is likely because of the use of US-specific life expectancy estimates in the present study, whereas the Global Burden of Diseases Study used the lowest death rate across countries for each age group to estimate US life expectancies.
Conclusions
The societal burden of SCD as measured by YPLL is highly relative to other major noncardiac conditions. Creation of a nationwide surveillance system for cardiovascular disease has been recognized as a priority. 22, 23 As the present study illustrates, the high societal burden of SCD alone could justify such a project. In areas where research collaborations between cardiology and emergency medicine systems are feasible, a network of nationally representative community-based studies of SCD could be developed to measure rates and modes of cardiovascular death and track them over time. Such an effort would facilitate a better understanding of SCD causes and a more accurate and timely assessment of the effectiveness of SCD prevention and treatment efforts.
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